Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

India’s Expanded Trial Waiver Proposal Sets R&D Site Inspection Clause

20 Jan 2017

• By Anju Ghangurde

Clinical trial

Related Content

India’s Trial Approval Timelines Report Card – Some Red Lines?

16 Jan 2017

Indian Clinical Research Sector: Hope And Despair Amid Shutdowns

26 Aug 2016

Industry Sponsored Trials Fall Sharply In Challenging Indian Environment

08 Sep 2016

Additional Topics

India Asia Pacific Regulation Clinical Trials Research & Development BioPharmaceutical

More from India

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.